Biography/Memoir

Investors are starting to bet big on psychedelic medicine…

Private investment in the space needs to be coupled with research into their social impact… Liana Gillooly, a development officer at MAPS, a non-profit investigating the therapeutic uses of psychedelics, with an early focus on MDMA as a potential treatment for PTSD. But Gillooly said that funding needs to be set aside for “safe contexts”…

READ MORE
Biography/Memoir

Are over-the-counter psychedelics in our future?

Mycologist Paul Stamets believes psilocybin should be offered over the counter. By whatever mechanism they work, psychedelics have long been shown to increase positive outlooks and decrease negative sentiments. That is valuable… We’ve exhausted the alternatives and found them insufficient. This is not medical advice—just common sense. Original Article (BigThink):Are over-the-counter psychedelics in our future?Artwork…

READ MORE
Biography/Memoir

Two black women helping to reclaim & encourage natural psychedelics use

“I want to model how to be a safe and responsible user without going the clinical route… for individuals who want to participate within a community-based environment, while receiving support and being safe.” -Co-founder Nicolle Greenheart (Decrim Nature Oakland) “I’m from Chicago, so there’s a regional difference in reception of natural plant medicines compared to Oakland. Indigenous…

READ MORE
Biography/Memoir

Former FDA chief wants federal government to regulate state marijuana markets

Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb [Pfizer Board Member] said… that the federal government should regulate state marijuana programs. He provided some clarification—hinting that federal drug scheduling laws should be reformed for cannabis — he is beginning to lay out specific details of a regulatory agenda. Gottlieb said during the TV interview that…

READ MORE
Biography/Memoir

Meet the Sacklers

What some call philanthropy, others, such as Stanford University ethics professor Rob Reich, call “reputation laundering”. But what’s less well known, though increasingly being exposed, is that much of their wealth comes from one product – OxyContin, the blockbuster prescription painkiller first launched in 1996. “Greed is the main thing. The market for OxyContin should have been much,…

READ MORE
Biography/Memoir

Oligarch of the month: the Sacklers

Joss Sackler, the entrepreneurial force behind a $2,500 per year social club and an allied clothing line, charged The New York Times to stop covering “the men in my life” and “review the fucking neon hoodies.” …are queasy about associating with the country’s most notorious limited liability cartel. The Guggenheim, for example, has stopped accepting donations from the Sackler…

READ MORE
Biography/Memoir

…opioid “settlement” plan

Luther Strange was championing… arguments against opioid lawsuits, he was also working behind the scenes as a paid attorney for members of the Sackler family… he’s a former US Senator from Alabama. …AGs are sticking to their demand that the Sacklers forfeit more of the personal fortune they amassed from opioid sales, valued at more…

READ MORE
Biography/Memoir

DEA… alleged Denver mushroom dealer…

*DEA Museum Opening [He] has not been charged or arrested. By the time [DEA] agents walked out of [the] apartment, they’d taken 906 live psychedelic mushrooms, 20.42 ounces of dried mushrooms … “Remember to use psilocybin safely and responsibly,” says Kevin Matthews, who led the campaign to get Initiative 301 passed by Denver voters. “And…

READ MORE
Biography/Memoir

Federal Court dismisses suit against DEA over marijuana growing applications

A federal court dismissed a lawsuit against the Drug Enforcement Administration (DEA)… after determining that the agency had fulfilled a requirement to process applications for research-grade marijuana manufacturers. The suit, brought by the Scottsdale Research Institute (SRI), argued that the marijuana grown at the University of Mississippi—currently the only facility that’s federally authorized to cultivate…

READ MORE
Biography/Memoir

One of Purdue Pharma’s owners, dies… amid a slew of multi-million dollar lawsuits against her family’s company

The Sacklers have expressed sympathy but refuse to take responsibility for the nation’s opioid epidemic. US Bankruptcy Judge Robert Drain agreed to pause the lawsuits against Purdue Pharma and the Sackler’s until next month with the intention of stopping suits longer so a settlement can be worked out. Drain gave the company, state attorneys general and lawyers…

READ MORE